Brief: Frequency Therapeutics Inc Announces New FX-322 Results
22/09/2021 14:33
Sept 22 (Reuters) - Frequency Therapeutics Inc FREQ.O :
* FREQUENCY THERAPEUTICS ANNOUNCES NEW FX-322 RESULTS
SHOWING THAT
ADDITIONAL STUDY PARTICIPANTS GAIN HEARING IMPROVEMENTS AT LATER
TIME POINTS
Source text for Eikon: ID:nBw1qb4Sya
Further company coverage: FREQ.O
Recent news on Korro Bio
See all newsBrief: Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Korro Announces First Cohort Dosed In Phase 1/2 Clinical Trial (Anchor) For Krro-121
Brief: Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Korro Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Korro Bio, Inc. expected to post a loss of $1.43 a share - Earnings Preview